JianqingLinMD

PubMed

• Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer.
  Zhang, Z., Luo, R., Kelly, W., Chen, J., Donahue, S., Ip, K., Handley, N., Tester, W., Tsang, M., Kim, F., Myers, R., Lu-Yao, G., Gu, J., Lin, J., Li, B., Wang, C., Ya...> ;Prostate Cancer and Prostatic Diseases. 2023 Dec 6
• Management of Localized Prostate Cancer in Men With Human Immunodeficiency Virus: Analysis of a Large Retrospective Cohort.
  Tina Vaziri, Yuan J Rao, Michael Whalen, Jeffrey Bethony, Punam Thakkar, Jianqing Lin, Sharad Goyal> ;Clinical Genitourinary Cancer. 2023 Oct 1
• 4 citations
  Belzutifan (MK-6482): Biology and Clinical Development in Solid Tumors.
  WonSeok W Choi, Julia L Boland, Akshar Kalola, Jianqing Lin> ;Current Oncology Reports. 2023 Feb 1
• 3 citations
  ONECUT2 as a key mediator of androgen receptor-independent cell growth and neuroendocrine differentiation in castration-resistant prostate cancer.
  WonSeok William Choi, Julia L Boland, Jianqing Lin> ;Cancer Drug Resistance. 2022 Jan 1
• 3 citations
  Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer.
  Jianqing Lin, Jacob Elkon, Brittany Ricart, Erica Palmer, Christian Zevallos-Delgado, Satish Noonepalle, Brooke Burgess, Robert S. Siegel, Yan Ma, Alejandro Villagra> ;The Oncologist. 2021 Sep 14
• 10 citations
  Cardiovascular Toxicity of Androgen Deprivation Therapy.
  Julia Boland, William Choi, Maximillian Lee, Jianqing Lin> ;Current Cardiology Reports. 2021 Jul 3
• 13 citations
  Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients.
  Weelic Chong, Zhenchao Zhang, Rui Luo, Jian Gu, Jianqing Lin, Qiang Wei, Bingshan Li, Ronald E. Myers, Grace L. Lu-Yao, William Kevin Kelly, Chun Wang, Hushan Yang> ;BMC Cancer. 2021 Jun 2
• 1 citations
  Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment
  Jialu Lv, Jianqing Lin> ;Asian Journal of Andrology. 2021 May 1
• 1 citations
  Sex-Biased Gene Expression and Evolution in the Cerebrum and Syrinx of Chinese Hwamei (Garrulax canorus).
  Hua Jiang, Jianqing Lin, Li Sun, Yan-Chun Xu, Sheng-Guo Fang> ;Genes. 2021 Apr 14
• 13 citations
  Hypoxia-Inducible Factor-2α as a Novel Target in Renal Cell Carcinoma.
  Won Seok W Choi, Julia Boland, Jianqing Lin> ;Journal of Kidney Cancer and VHL. 2021 Apr 7
• 3 citations
  Genome-Wide DNA Methylation and Transcriptome Analyses Reveal Epigenetic and Genetic Mechanisms Underlying Sex Maintenance of Adult Chinese Alligator
  Jianqing Lin, Jun Yu, Li Sun, Sheng-Guo Fang> ;Frontiers in Genetics. 2021 Mar 11
• 16 citations
  Improved prognostic stratification using circulating tumor cell clusters in patients with metastatic castration-resistant prostate cancer
  Chun Wang, Zhenchao Zhang, Weelic Chong, Rui Luo, Ronald E. Myers, Jian Gu, Jianqing Lin, Qiang Wei, Bingshan Li, Timothy R. Rebbeck, Grace L. Lu-Yao, William Kevin Ke...> ;Cancers. 2021 Jan 13
• 3 citations
  Multi-omics analysis reveals that natural hibernation is crucial for oocyte maturation in the female Chinese alligator
  Jianqing Lin, Jun Yu, Hua Jiang, Yi Zhang, Qiu-Hong Wan, Sheng-Guo Fang> ;BMC Genomics. 2020 Nov 10
• 11 citations
  A Unique Energy-Saving Strategy during Hibernation Revealed by Multi-Omics Analysis in the Chinese Alligator.
  Jianqing Lin, Yun-Yi Huang, Meng-Yao Bian, Qiu-Hong Wan, Sheng-Guo Fang> ;Iscience. 2020 Jun 26
• 1 citations
  Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer.
  Jianqing Lin, Robert B. Den, Jacob Greenspan, Timothy N. Showalter, Jean H. Hoffman-Censits, Costas D. Lallas, Edouard J. Trabulsi, Leonard G. Gomella, Mark D. Hurwitz...> ;International Journal of Radiation Oncology, Biology, Physics. 2020 Apr 1
• 2 citations
  ONECUT2 is a novel target for treatment of castration-resistant prostate cancer.
  Tejashree Joglekar, Jianqing Lin, Maho Shibata> ;Expert Opinion on Therapeutic Targets. 2020 Feb 3
• 4 citations
  A Pilot Study of Radiation Therapy in Combination With Pembrolizumab in Patients With Metastatic Renal Cell Cancer.
  Jianqing Lin, Andrew Song, Jean H. Hoffman-Censits, Benjamin E. Leiby, Madalina Tuluc, Colette M. Shaw, Larry Harshyne, Rhonda B. Kean, Voichita Bar-Ad, Robert B. Den,...> ;American Journal of Clinical Oncology. 2020 Feb 1
• 3 citations
  Racial disparities in late-stage prostate cancer: a SEER analysis 2005-2015.
  Stephanie Rodriguez, Andrew D. Sparks, Hanbing Zhou, Richard L Amdu, Jianqing Lin> ;The Canadian Journal of Urology. 2019 Oct 1
• 12 citations
  IDSSR: An Efficient Pipeline for Identifying Polymorphic Microsatellites from a Single Genome Sequence
  Xuanmin Guang, Jin-Quan Xia, Jianqing Lin, Jun Yu, Qiu-Hong Wan, Sheng-Guo Fang> ;International Journal of Molecular Sciences. 2019 Jul 16
• 7 citations
  Severe Hypocalcemia and Hypomagnesemia with Denosumab in Advanced Chronic Kidney Disease: Case Report and Literature Review.
  Christina F. Marlow, Shailendra Sharma, Faizan Babar, Jianqing Lin> ;Case Reports in Oncological Medicine. 2018 Oct 14
• 21 citations
  Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial
  Fern Anari, John O'Neill, Woonyoung Choi, David Y.T. Chen, Mohammed Haseebuddin, Alexander Kutikov, Essel Dulaimi, R. Katherine Alpaugh, Karthik Devarajan, Richard E. ...> ;European Urology Oncology. 2018 May 1
• 2 citations
  Abiraterone is effective and should be considered for the treatment of metastatic castrate-naïve prostate cancer.
  Jacob Elkon, Ralph L. Millett, Kristin F Millado, Jianqing Lin> ;Expert Opinion on Pharmacotherapy. 2018 Mar 1
• 24 citations
  Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies.
  Tu Dan, Harriet Eldredge-Hindy, Jean H. Hoffman-Censits, Jianqing Lin, William Kevin Kelly, Leonard G. Gomella, Costas D. Lallas, Edouard J. Trabulsi, Mark D. Hurwitz,...> ;American Journal of Clinical Oncology. 2017 Aug 1
• 83 citations
  Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study
  Yinzhi Lai, Chun Wang, Jesse Civan, Juan P. Palazzo, Zhong Ye, Terry Hyslop, Jianqing Lin, Ronald E. Myers, Bingshan Li, Bing-Hua Jiang, Ashwin Reddy Sama, Jinliang Xi...> ;Gastroenterology. 2016 May 1
• Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
  Hyun Kim, Mohammed Alshalalfa, Jean H. Hoffman-Censits, Costas D. Lallas, Elai Davicioni, Jianqing Lin, Ruth Birbe, Nicholas Erho, Jonathan Lehrer, Hussam Al-Deen Asha...> ;Urology Case Reports. 2016 Nov 1
• Join now to see all

Journal Articles

• Phase I/II Study of Orteronel (TAK-700), an Oral, Investigational, Nonsteroidal 17,20-lyase Inhibitor, with Docetaxel and Prednisone (DP) In Metastatic Castration-resi...  
  Petrylak DP, Ghandi JG, Clark WK, Heath E, Lin J, Oh WK, Agus DB, Carthon B, Moran S, Kong N, Suri A, Bargfrede M, Liu G, Invest New Drugs, 1/1/2015
• An Open Label Randomized Phase II Study of Pasireotide with or without Everolimus in Castrate-resistant Chemotherapy-naive Prostate Cancer Patients  
  Lin J, Deng A, Hoffman-Censits J, Gibney G, Hyslop T, Miller B, Kilpatrick D, Jabbour S, Kelly WK, Cancer Treatment Communications, 1/1/2015
• Change in PSA Velocity Is a Predictor of Overall Survival in Men with Biochemically-recurrent Prostate Cancer Treated with Nonhormonal Agents: Combined Analysis of Fou...  
  Suzman DL, Zhou XC, Zahurak ML, Lin J, Antonarakis ES, Prostate Cancer Prostatic Dis, 1/1/2015
• Immune Biomarkers of Treatment Failure for a Patient with Renal Cell Carcinoma on a Phase I Trial of Pembrolizumab plus Radiotherapy  
  Alexander G, Palmer J, Tuluc M, Lin J, D Craig Hooper DC, Lu B, Journal for ImmunoTherapy of Cancer, 1/1/2015
• Accelerated Methotrexate, Vinblastine, Doxorubicin and Cisplatin (AMVAC) Is Safe, Effective and Efficient Neoadjuvant Treatment for Muscle Invasive Bladder Cancer: Res...  
  Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, ..., J Clin Oncol, 1/20/2014
• A Pilot Phase II Study of Digoxin in Patients with Recurrent Prostate Cancer as Evident by a Rising PSA  
  Lin J, Zhan T, Duffy D, Hoffman-Censits J, Kilpatrick D, Trabulsi EJ, Lallas CD, Chervoneva I, Limentani K, Kennedy B, Kessler S, Gomella L, Antonarakis ES, Carducci M..., Am J Cancer Ther Pharmacol., 1/7/2014
• Pharmacodynamic study of Disulfiram in Men with Non-metastatic Recurrent Prostate Cancer  
  Schweizer M, Lin J, Blackford A, Bardia A, King S, Armstrong SJ, Rudek MA, Yegnasubramanian S, Carducci MA, Prostate Cancer and Prostatic Diseases, 1/1/2013
• A Non-comparative Randomized Phase II Study of 2 Doses of ATN-224, a Copper/zinc Superoxide Dismutase Inhibitor, in Patients with Biochemically Recurrent Hormone-naive...  
  Lin J, Zahurak M, Beer TM, Ryan CJ, Wilding G, Mathew P, Morris M, Callahan JA, Gordon G, Reich SD, Carducci MA, Antonarakis ES, Urol Oncol, 1/1/2013
• Changes in PSA Kinetics Predict Metastasis-Free Survival in Men with PSA-Recurrent Prostate Cancer Treated with Non-Hormonal Agents: Combined Analysis of 4 Phase II Tr...  
  Antonarakis ES, Zahurak ML, Lin J, Keizman D, Carducci MA, and Eisenberger MA, Cancer, 1/1/2012
• Phase I Trial with a Combination of Docetaxel (Tax) and 153 Sm-EDTMP (Sm) in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC) )  
  Lin J, Sinibaldi VJ, Carducci MA, Denmeade S, Song D, DeWeese T, Eisenberger MA, Urologic Oncology, 1/1/2011
• Disulfiram Is a Novel DNMT1 Inhibitor and Inhibits Prostate Cancer Cell Growth  
  Lin J, Haffner MC, Zhang Y, Lee BH, Kachhap S, Nelson WG, Yegnasubramanian S, Carducci MA, Prostate, 1/31/2010
• Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Cells Is Mediated through Downregulation of the E2F1 Transcription Fa...  
  Kachhap SK, Rosmus N, Collis SJ, Kortenhorst M, Wissing MD, Hedayati M, Shabbeer S, Mendonca J, Deangelis J, Marchionni L, Lin J, Nortier JWR, DeWeese TL, Hammers H an..., Molecular Cancer PLoS One, 1/18/2010
• A Phase I/II Dose Finding Study of 5-Azacytidine in Combination with Sodium Phenybutyrate in Patients with Refractory Solid Tumors  
  Lin J, Gilbert J, Rudek MA, Zweibel JA, Gore S, Jiemijt A, Zaho M, Baker SD, Ambinder RF, Herman JG, Donehower RC, Carducci MA, Clinical Cancer Research, 1/1/2009
• An Oxidative Stress Mechanism Mediates Chelerythrine-induced Heparin-binding EGF-like Growth Factor Ectodomain Shedding  
  Kim J, Lin J, Adam RM, Lamb C, Shively SB, Freeman MR, J Cell Bichem, 1/1/2005
• Transactivation of ErbB1 and ErbB2 Receptors by Angiotensin II in Normal Human Prostate Stromal Cells  
  Lin J. and Freeman MR, Prostate, 1/1/2003
• A Nuclear Form of the Heparin-binding Epidermal Growth Factor-like Growth Factor Precursor Is a Feature of Aggressive Transitional Cell Carcinoma  
  Adam RM, Danciu T, McLellan DL, Borer JG, Lin J, Zurakowski D, Weinstein MH, Rajjayabun PH, Mellon JK, Freeman MR, Cancer Res, 1/1/2003
• Cholesterol-rich Lipid Rafts Mediate Akt-regulated Survival in Prostate Cancer Cells  
  Zhuang L, Lin J, Lu ML, Solomon KR, Freeman MR, Cancer Res, 1/1/2002
• Heparin-binding EGF-like Growth Factor Stimulates Androgen-independent Prostate Tumor Growth and Antagonizes Androgen Receptor Function  
  Adam RA, Kim J., Lin J., Orsola A., Zhuang L., Rice DC, and Freeman MR, Endocrinology, 1/1/2002
• BAG-1 Is a Novel Cytoplasmic Binding Partner of the Membrane Form of Heparin-binding EGF-like Growth Factor, a Unique Role for ProHB-EGF in Cell Survival Regulation  
  Lin J., Hutchinson L., Gaston SM., Raab G., and Freeman MR, J Biol Chem, 1/1/2001
• Heparin-binding Epidermal Growth Factor-like Growth Factor Is an Autocrine Mediator of Human Prostate Stromal Cell Growth in Vitro  
  Duque JL, Adam RM, Mullen JS, Lin J, Richie JP, Freeman MR, J Urol., 1/1/2001
• Heparin-binding EGF-like Growth Factor Is Up- Regulated in the Obstructed Kidney in a Cell- and Region-specific Manner and Acts to Inhibit Apoptosis  
  Nguyen HT, Bride SH, Badawy AB, Adam RM, Lin J, Orsola A, Guthrie PD, Freeman MR, and Peters CA, Am J Pathol, 1/1/2000
• The Phosphatidylinositol 3'-kinase Pathway Is a Dominant Growth Factor-activated Cell Survival Pathway in LNCaP Human Prostate Carcinoma Cells  
  Lin J., Adam R., and Freeman M, Cancer Res, 1/1/1999
• An EGFR Antisense Oligodeoxynucleotides and Its Phosphorothioate Analogues Inhibit the Growth of Human Hepatocarcinoma BEL-7404 Cells  
  Lin JQ, Xu ZS., Zhang HY., Yang ZH., and Xu YH, Shih-Yen-Sheng-Wu-Hsueh-Pao, 1/1/1995
• A Study of Effects and Mechanism of Retinoic Acid on Inducing Differentiation of Mouse Lymphoma SACIIB2 Clone Cells  
  Lin J, Kong X and Cheng L, Acta Academiae Medicinae Shanghai, 1/1/1994
• Retinoic Acid Induces Differentiation of Human T Lymphocytic Leukemia CCRF-CEM Cells  
  Lin JQ, Zhonghua Zhong Liu Za Zhi., 1/1/1993
• Join now to see all

Abstracts/Posters

• A phase I/II study of the investigational drug alisertib in combination with abiraterone and prednisone (AP) for patients with metastatic castration-resistant prostate...
  Jianqing Lin, Ashwin R. Sama, Jean. H. Hoffman-Censits, Brooke Kennedy, Debraoh Kilpatrick, Ye Zhong, Hushan Yang, Zhaomei Mu, Benjamin E. Leiby, Nancy Lewis, Massimo ..., 2016 GU ASCO Symposium, 2016